{
    "clinical_study": {
        "@rank": "151185", 
        "arm_group": [
            {
                "arm_group_label": "aleglitazar", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This multicenter, randomized, double-blind, placebo-controlled study will assess the\n      efficacy, safety and tolerability of aleglitazar compared with placebo when added to a\n      sulfonylurea monotherapy or sulfonylurea plus metformin combination therapy in patients with\n      type 2 diabetes mellitus who are inadequately controlled with sulfonylurea alone or\n      sulfonylurea plus metformin therapy. Patients will be randomized to receive oral doses of\n      150 mcg aleglitazar once daily or placebo. The anticipated time on study treatment is 26\n      weeks."
        }, 
        "brief_title": "A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes Mellitus, Type 2", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients, >/=18 years of age\n\n          -  Diagnosis of diabetes mellitus, type 2\n\n          -  Patients treated with stable sulfonylurea monotherapy or sulfonylurea plus metformin\n             combination therapy for at least 12 weeks prior to screening\n\n          -  HbA1c >/=7% and </=9.5% at screening or within 4 weeks prior to screening and at\n             pre-randomization visit\n\n          -  Fasting plasma glucose </=240 mg/dL at pre-randomization visit\n\n          -  Agreement to maintain diet and exercise habits during the study\n\n        Exclusion Criteria:\n\n          -  Patients with Type 1 diabetes mellitus, secondary diabetes, diabetes resulting from\n             pancreatic injury, or acute metabolic diabetic complications within the past 6 months\n\n          -  Any previous treatment with thiazolidinedione or a dual PPAR agonist\n\n          -  Any body weight lowering or lipoprotein-modifying therapy within 12 weeks prior to\n             screening (except stable dose of statin)\n\n          -  Any anti-hyperglycemic medication other than sulfonylurea alone or in combination\n             with metformin within 12 weeks prior to screening\n\n          -  Symptomatic congestive heart failure classified as New York Heart Association class\n             II-IV at screening"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "197", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01691989", 
            "org_study_id": "WC28325"
        }, 
        "intervention": [
            {
                "arm_group_label": "aleglitazar", 
                "description": "150 mcg orally once a day for 26 weeks", 
                "intervention_name": "aleglitazar", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "oral doses once a day for 26 weeks", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Metformin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chino", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91710"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90057"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92161"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santa Ana", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92701"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32216"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kissimmee", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34741"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St Petersburg", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33716"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30338"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Avon", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46123"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bethesda", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20817"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27713"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Morrisville", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19067"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greer", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29651"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75230"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23249"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "1056"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caba", 
                        "country": "Argentina", 
                        "zip": "C1428DCO"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rosario", 
                        "country": "Argentina", 
                        "zip": "S2000CXP"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bogota", 
                        "country": "Colombia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Floridablanca", 
                        "country": "Colombia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medellin-Antioquia", 
                        "country": "Colombia"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guatemala", 
                        "country": "Guatemala", 
                        "zip": "01014"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guatemala", 
                        "country": "Guatemala", 
                        "zip": "01010"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aguascaliente", 
                        "country": "Mexico", 
                        "zip": "20230"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Celaya", 
                        "country": "Mexico", 
                        "zip": "38000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guadalajara", 
                        "country": "Mexico", 
                        "zip": "44650"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guadalajara", 
                        "country": "Mexico", 
                        "zip": "44600"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Queretaro", 
                        "country": "Mexico", 
                        "zip": "7600"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Colombia", 
                "Guatemala", 
                "Mexico"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PHASE III STUDY TO ASSESS THE EFFICACY,SAFETY AND TOLERABILITY OF ALEGLITAZAR ADDED TO A SU OR ADDED TO A SU IN COMBINATION WITH MET IN PATIENTS WITH T2D INADEQUATELY CONTROLLED WITH SU MONOTHERAPY OR WITH SU + METFORMIN COMBINATION THERAPY", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in hemoglobin HbA1c", 
            "safety_issue": "No", 
            "time_frame": "From baseline to week 26"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01691989"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in lipid profile", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 26"
            }, 
            {
                "measure": "Change from baseline in fasting plasma glucose", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 26"
            }, 
            {
                "measure": "Responder rate as defined of hemoglobin HbAc1 <7.0% (<6.5%)", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 26"
            }, 
            {
                "measure": "Change from baseline in homeostatic index of insulin sensitivity (HOMA-IS)", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 26"
            }, 
            {
                "measure": "Change from baseline in markers of insulin sensitivity and cardiovascular risk", 
                "safety_issue": "No", 
                "time_frame": "From baseline to week 26"
            }, 
            {
                "measure": "Safety: incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "30 weeks (26 weeks treatment and 4 weeks follow-up)"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}